You are here

Latest news & updates

11 October 2021
Safety advisory - Risk of pigmentary maculopathy (changes in the retina of the eye), especially after long-term use
11 October 2021
Health professionals are advised that the Product Information for pentosan polysulfate sodium has been updated with a warning about potential pigmentary maculopathy, especially after long-term use.
11 October 2021
UDI No.4 Webinar presentation providing information on the creation of UDIs and the role of an Issuing Agency.
8 October 2021
A meeting statement is now available for the last Advisory Committee on Complementary Medicines meeting
8 October 2021
Notice of final decision in relation to nitrous oxide - Joint ACMS-ACCS#27 (March 2021)
7 October 2021
AIVC recommendations for the composition of influenza vaccine for Australia in 2022.
7 October 2021
Australian prescription medicine decision summary
7 October 2021
Australian Public Assessment Report for Eslicarbazepine acetate
6 October 2021
GMDN guidance is to assist sponsors and manufacturers when applying for inclusion in the ARTG and selecting a GMDN term.
5 October 2021
On 1 October 2021, the TGA granted provisional determination to Pfizer Australia in relation to a new combination medicine containing PF-07321332 and ritonavir, for the treatment of adult patients with symptomatic, confirmed coronavirus infection.

Pages

Subscribe to Latest news & updates